Quant Large & Mid Cap Fund - Growth Option-Direct Plan

  • Previous Nav

  • Net Change on 11-08-2020

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate capital appreciation & provide long term growth opportunities by investing in a portfolio of Large Cap and Mid Cap companies. There is no assurance that the investment objective of the Scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Quant Large & Mid Cap Fund - Growth Option-Direct Plan 5.23 18.08 20.12 5.82 9.91 15.11
Nifty LargeMidcap 250 Index 5.63 23.42 4.25 N/A N/A 0.54

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Quant Large & Mid Cap Fund - Growth Option-Direct Plan Jan 07, 2013 20.12 5.82 9.91 2.38 4.92
Mirae Asset Emerging Bluechip Fund - Direct Plan - Growth Jan 01, 2013 11.15 8.88 12.87 0.85 10,596.23
Canara Robeco Emerging Equities-Direct Plan-Growth Option Jan 01, 2013 12.48 6.30 9.69 0.77 5,543.36
DSP Equity Opportunities Fund - Direct Plan - Growth Dec 31, 2012 5.57 3.67 8.11 1.00 4,889.15
Aditya Birla Sun Life Equity Advantage Fund - Growth - Direct Plan Jan 01, 2013 4.75 -0.06 5.89 1.08 4,264.78
Kotak Equity Opportunities Fund - Growth - Direct Jan 01, 2013 8.63 5.28 8.43 0.89 3,517.10

Fund Holdings as on 31-July-2020

  • Ajanta Pharma Ltd

  • Adani Gas Limited

  • Aurobindo Pharma Ltd

  • Nestle India Ltd.

  • Hindustan Unilever Ltd.

  • Biocon Ltd

  • Bharti Airtel Limited

  • Cadila Healthcare Ltd

  • SRF Limited

  • Aarti Industries Ltd

  • Siemens Ltd

  • Power Finance Corporation Ltd.

  • Godrej Agrovet Limited

  • PI Industries Ltd

  • Oil and Natural Gas Corporation Ltd.

  • Max Financial Services Ltd

  • (b) Other Receivables (Payables)

  • Vinati Organics Ltd

  • Natco Pharma Ltd

  • ITC Ltd.

  • TREPS 03-Aug-2020 DEPO 10

  • Gillette India Ltd

  • Aarti Surfactants Ltd

View More
  • Pharmaceuticals & Drugs

  • Consumer Food

  • Trading

  • Household & Personal Products

  • Telecommunication - Service Provider

  • Chemicals

  • Diversified

  • Electric Equipment

  • Miscellaneous

  • Finance Term Lending

  • Pesticides & Agrochemicals

  • Oil Exploration

  • Finance - Others

  • Cigarettes/Tobacco

  • Unspecified

View More

Fund Manager

  • Cash

  • Equity

View More

About Quant Large & Mid Cap Fund

NULL

Scheme Analysis

Quant Large & Mid Cap Fund is a Equity - Large & Mid Cap Fund fund and belongs to Quant Mutual Fund. It was launched on 07-Jan-2013 and currently has an AUM of ₹4.92 crore. Quant Large & Mid Cap Fund is benchmarked against Nifty LargeMidcap 250 Index as primary index.

The NAV of Quant Large & Mid Cap Fund ended down ₹-0.59(-1.4%)yesterday to ₹41.7202.

Among its top 3 holdings the fund has exposure to Ajanta Pharma Ltd, and

The Quant Large & Mid Cap Fund is managed by Sanjeev Sharma and Vasav Sahgal.

Fund House Contact

11, Scindia House, Connaught Circus, New Delhi - 110 001

011-43587415, 43587420
help@quant.in
011-43587432